December 2003

Patent It in Canada logo in a gray background | Patent It in Canada
Intellectual Property
Patent It in CanadaPatent It in Canada
Patent It in Canada
Dec 1, 2003
byBPI Contributor
Indian Biotech on the Rise logo in a gray background | Indian Biotech on the Rise
Bioregions
Indian Biotech on the RiseIndian Biotech on the Rise
Indian Biotech on the Rise
Dec 1, 2003
byBPI Contributor
NS0 Serum-Free Culture and Applications logo in a gray background | NS0 Serum-Free Culture and Applications
Cell Culture Media
NS0 Serum-Free Culture and ApplicationsNS0 Serum-Free Culture and Applications
NS0 Serum-Free Culture and Applications
Dec 1, 2003
byBPI Contributor
Changes in US Immigration Law logo in a gray background | Changes in US Immigration Law
Business
Changes in US Immigration LawChanges in US Immigration Law
Changes in US Immigration Law
Dec 1, 2003
byBPI Contributor
Case Studies in Contract Biomanufacturing logo in a gray background | Case Studies in Contract Biomanufacturing
Contract Services
Case Studies in Contract BiomanufacturingCase Studies in Contract Biomanufacturing
Case Studies in Contract Biomanufacturing
Dec 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature December 2003Products, Services, and Literature December 2003
Products, Services, and Literature
Dec 1, 2003
byBPI Contributor
Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells logo in a gray background | Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Cell Therapies
Stimulating Extracellular Matrix Production By Inter vertebral Disc CellsStimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Dec 1, 2003
byBPI Contributor
A Useful Resource logo in a gray background | A Useful Resource
Business
A Useful ResourceA Useful Resource
A Useful Resource
Dec 1, 2003
byBPI Contributor
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor logo in a gray background | Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
MAb
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank BioreactorProducing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
Dec 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024